KR970704426A - 오메프라졸의 마그네슘 염을 함유한 신규의 경구 제약 제형(New Oral Pharmaceutical Formulation Containing Magnesium Salt of Omeprazole) - Google Patents
오메프라졸의 마그네슘 염을 함유한 신규의 경구 제약 제형(New Oral Pharmaceutical Formulation Containing Magnesium Salt of Omeprazole) Download PDFInfo
- Publication number
- KR970704426A KR970704426A KR1019970700059A KR19970700059A KR970704426A KR 970704426 A KR970704426 A KR 970704426A KR 1019970700059 A KR1019970700059 A KR 1019970700059A KR 19970700059 A KR19970700059 A KR 19970700059A KR 970704426 A KR970704426 A KR 970704426A
- Authority
- KR
- South Korea
- Prior art keywords
- formulation
- omeprazole
- enteric
- core material
- mammals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SEPCT/SE94/00679 | 1994-07-08 | ||
SE9400679 | 1994-07-08 | ||
PCT/SE1995/000816 WO1996001622A1 (en) | 1994-07-08 | 1995-07-03 | New oral pharmaceutical formulation containing magnesium salt of omeprazole |
Publications (1)
Publication Number | Publication Date |
---|---|
KR970704426A true KR970704426A (ko) | 1997-09-06 |
Family
ID=20393105
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970700059A KR970704426A (ko) | 1994-07-08 | 1995-07-05 | 오메프라졸의 마그네슘 염을 함유한 신규의 경구 제약 제형(New Oral Pharmaceutical Formulation Containing Magnesium Salt of Omeprazole) |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0768872A1 (pl) |
KR (1) | KR970704426A (pl) |
BR (1) | BR9508261A (pl) |
CA (1) | CA2193681A1 (pl) |
CZ (1) | CZ379596A3 (pl) |
EE (1) | EE03378B1 (pl) |
FI (1) | FI970058A0 (pl) |
HU (1) | HUT78132A (pl) |
IS (1) | IS4398A (pl) |
MX (1) | MX9700152A (pl) |
NO (1) | NO970036L (pl) |
NZ (1) | NZ289958A (pl) |
PL (1) | PL181265B1 (pl) |
SK (1) | SK166096A3 (pl) |
WO (1) | WO1996001622A1 (pl) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US5900258A (en) * | 1996-02-01 | 1999-05-04 | Zeolitics Inc. | Anti-bacterial compositions |
SI9700186B (sl) | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin |
US6096340A (en) | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
SE9802973D0 (sv) | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
US6316020B1 (en) * | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
EP1263445A1 (en) * | 2000-03-09 | 2002-12-11 | Ian Whitcroft | Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin, metronidazole and a gastrointestinal hydrogen pump inhibitor |
EP1133987A1 (en) * | 2000-03-09 | 2001-09-19 | Ian Whitcroft | Treatment of inflammatory dermatoses with combinations of erythromycin or clarythromycin, metronidazole and a hydrogen pump inhibitor |
EP1552833B1 (en) | 2002-10-16 | 2016-12-28 | Takeda Pharmaceutical Company Limited | Process for producing an amorphous optically active isomer of lansoprazole |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CA2570796A1 (en) * | 2004-06-15 | 2006-01-05 | Teva Pharmaceutical Industries Ltd. | Stable pharmaceutical formulations of benzimidazole compounds |
CN105106168B (zh) * | 2015-08-19 | 2018-03-06 | 德州德药制药有限公司 | 一种埃索美拉唑镁肠胶囊及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
JPH0768125B2 (ja) * | 1988-05-18 | 1995-07-26 | エーザイ株式会社 | 酸不安定化合物の内服用製剤 |
SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
-
1995
- 1995-07-03 MX MX9700152A patent/MX9700152A/es unknown
- 1995-07-03 EE EE9700014A patent/EE03378B1/xx not_active IP Right Cessation
- 1995-07-03 HU HU9700039A patent/HUT78132A/hu unknown
- 1995-07-03 WO PCT/SE1995/000816 patent/WO1996001622A1/en not_active Application Discontinuation
- 1995-07-03 CA CA002193681A patent/CA2193681A1/en not_active Abandoned
- 1995-07-03 BR BR9508261A patent/BR9508261A/pt not_active Application Discontinuation
- 1995-07-05 NZ NZ289958A patent/NZ289958A/en unknown
- 1995-07-05 CZ CZ963795A patent/CZ379596A3/cs unknown
- 1995-07-05 SK SK1660-96A patent/SK166096A3/sk unknown
- 1995-07-05 KR KR1019970700059A patent/KR970704426A/ko not_active Application Discontinuation
- 1995-07-05 PL PL95318464A patent/PL181265B1/pl unknown
- 1995-07-05 EP EP95926067A patent/EP0768872A1/en not_active Withdrawn
-
1996
- 1996-12-17 IS IS4398A patent/IS4398A/is unknown
-
1997
- 1997-01-06 NO NO970036A patent/NO970036L/no not_active Application Discontinuation
- 1997-01-07 FI FI970058A patent/FI970058A0/fi unknown
Also Published As
Publication number | Publication date |
---|---|
HUT78132A (hu) | 2000-06-28 |
EP0768872A1 (en) | 1997-04-23 |
NO970036D0 (no) | 1997-01-06 |
AU695723B2 (en) | 1998-08-20 |
CA2193681A1 (en) | 1996-01-25 |
NZ289958A (en) | 1998-09-24 |
CZ379596A3 (en) | 1997-08-13 |
EE9700014A (et) | 1997-06-16 |
FI970058A (fi) | 1997-01-07 |
EE03378B1 (et) | 2001-04-16 |
WO1996001622A1 (en) | 1996-01-25 |
HU9700039D0 (en) | 1997-02-28 |
IS4398A (is) | 1996-12-17 |
PL318464A1 (en) | 1997-06-09 |
PL181265B1 (pl) | 2001-06-29 |
BR9508261A (pt) | 1997-12-23 |
NO970036L (no) | 1997-01-06 |
WO1996001622A8 (en) | 1999-12-23 |
FI970058A0 (fi) | 1997-01-07 |
AU2994795A (en) | 1996-02-09 |
MX9700152A (es) | 1997-04-30 |
SK166096A3 (en) | 1997-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970704426A (ko) | 오메프라졸의 마그네슘 염을 함유한 신규의 경구 제약 제형(New Oral Pharmaceutical Formulation Containing Magnesium Salt of Omeprazole) | |
RU96102154A (ru) | Новая фармацевтическая композиция, способ ее получения, способ лечения заболеваний с использованием композиции | |
KR870009717A (ko) | 신규 경구용 약제 | |
KR880002673B1 (ko) | 진통 캡슐제와 그 제조방법 | |
JP4907765B2 (ja) | 経口医薬パルス放出剤形 | |
TWI232755B (en) | Oral medicament, and a supporting substrate complex of oral medicament | |
DE60032749T2 (de) | Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin | |
US5409709A (en) | Antipyretic analgesic preparation containing ibuprofen | |
US4505890A (en) | Controlled release formulation and method | |
DK158562B (da) | Diffusionsovertrukket polydepotpraeparat og fremgangsmaade til fremstilling deraf | |
CA2835364C (en) | Pharmaceutical composition of rosuvastatin calcium | |
KR870009718A (ko) | 경구용 산에 불안정한물질의 약제 | |
MXPA05001538A (es) | Distribuidor de tipo manguito de endoscopio. | |
KR100429489B1 (ko) | 위장관에서의 활성 화합물의 방출을 조절하기 위한 로젠지 | |
US5397574A (en) | Controlled release potassium dosage form | |
JP2007532689A (ja) | 医薬有効成分の遅延性かつ調節性放出のための微粒子経口ガレヌス製剤 | |
IL121652A (en) | Pharmaceutical dosage forms for oral administration that include a proton pump inhibitor and a prokinetic substance | |
PT96078A (pt) | Processo de preparacao de composicoes farmaceuticas contendo cimetidina | |
EA006398B1 (ru) | Фармацевтические композиции для координированной доставки нестероидных противовоспалительных лекарственных средств | |
PT101085B (pt) | Novas formas de dosagem de risedronato | |
JPS61275211A (ja) | 治療薬粒子 | |
NO157805B (no) | Fremgangsmaate for fremstilling av et preparat for behandling av urinveisinfeksjoner. | |
KR20190092805A (ko) | 아세틸살리실산 및 란소프라졸을 포함하는 약학적 조성물 | |
JP3170855B2 (ja) | イブプロフェン含有解熱鎮痛剤 | |
GB2132887A (en) | Enteric-coated anti-inflammatory compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |